Over 1 million additional men were likely to have been incorrectly diagnosed and treated for prostate cancer.

On Thursday, U.S. researchers stated that the so-called breast cancer genes (BRCA1 and BRCA2) can raise the risk that a man who develops prostate cancer will get an aggressive form of the disease.

First Time That Math Prize Is Awarded for Medical Treatment and Prostate Cancer in This Case.

Results from a phase III drug trial indicate that an anti-anemia drug did not significantly decrease the need for blood transfusions in patients not on chemotherapy, and decreased overall patient survival when compared to placebo, according to researchers from the UCLA Medical Center at the 2007 Annual Meeting of the American Association for Cancer Research.

Illumina, Inc. today announced that scientists from the National Cancer Institute, part of the National Institutes of Health , and their partners in the Cancer Genetic Markers of Susceptibility initiative identified a specific single nucleotide polymorphism (SNP), rs6983267, that strongly correlates to the development of prostate cancer, a disease that more than 218,000 men in the United States will be diagnosed with this year

A study by biomedical scientists at the University of Leicester has revealed for the first time that rice bran could reduce the risk of intestinal cancer.